Capmatinib and Fezolinetant: Interaction Details

Brand names
Capmatinib
Tabrecta
Fezolinetant
Veozah
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

What Happens When You Take Capmatinib With Fezolinetant

What can happen when they are taken together (rated Contraindicated)

Increased fezolinetant exposure

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Because fezolinetant is a of , giving it together with a CYP1A2 of any strength (strong, moderate or weak) raises its , and such combinations are therefore . Evidence from clinical studies and model-informed approaches shows that when fezolinetant was taken alongside the strong CYP1A2 inhibitor fluvoxamine, its rose by 840% and its by 80%.

With the moderate CYP1A2 inhibitor mexiletine, given at 400 mg every 8 hours, fezolinetant AUC was 360% higher and Cmax 40% higher. of the weak CYP1A2 inhibitor cimetidine, at 300 mg every 6 hours, produced a 100% rise in fezolinetant AUC and a 30% rise in Cmax.1

The Capmatinib and Fezolinetant Interaction, Explained

Capmatinib (Tabrecta) is a cancer medicine for a type of lung cancer. Fezolinetant is a newer medicine that helps with hot flashes during menopause. Capmatinib slows down a liver enzyme (called ) that your body uses to clear fezolinetant. When that happens, fezolinetant can build up to much higher levels than intended, which raises the chance of side effects, including effects on the liver.

Because of this, these two medicines are not meant to be taken together. Please don't stop either one on your own. Talk with your pharmacist or doctor soon. Your care team can help find a safe plan for treating your hot flashes alongside your cancer treatment.

Mechanism: Capmatinib is a moderate . It reduces CYP1A2-mediated of fezolinetant, a CYP1A2 . This increases fezolinetant exposure.

  • Magnitude (class data): With moderate (mexiletine), fezolinetant rose about 40% and about 360%. With strong inhibition (fluvoxamine), Cmax rose 80% and AUC 840%. Even weak inhibition (cimetidine) doubled AUC.
  • Evidence: Probable. This is based on clinical and model-informed data with other CYP1A2 .
  • Onset: Unspecified.
  • Management: per fezolinetant labeling. Avoid . Consider non-interacting alternatives for vasomotor symptoms in consultation with oncology.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Capmatinib and Fezolinetant Interact

The likely mechanism

of -mediated of fezolinetant

In short: Capmatinib slows CYP1A2, an enzyme that breaks down fezolinetant, so fezolinetant can build up in the body.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When One Drug Raises Another’s Level”, one chapter of our one-minute explainer. See how it works 

How to Manage the Capmatinib and Fezolinetant Interaction

The labeling for fezolinetant lists this combination as , meaning the two should not be used together. Here is what that usually looks like in practice:

  • Your care team will typically choose a different approach for hot flashes so your cancer treatment with capmatinib can continue as planned.
  • Do not stop or change either medicine on your own.
  • Tell your pharmacist and prescribers about every medicine you take, including both of these, so they can coordinate a safe plan.
  • Ask your doctor or pharmacist about other options for managing menopause symptoms.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Capmatinib or Fezolinetant need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

3 reports from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: Veozah oral tablets, fezolinetant oral tablets

    According to data derived from clinical studies and model-informed approaches, with fluvoxamine (a strong ) resulted in an 80% increase in fezolinetant and an 840% increase in fezolinetant .1

  2. Report 2 · Study title

    Prescribing information: Veozah oral tablets, fezolinetant oral tablets

    When fezolinetant was given together with mexiletine (a moderate ) 400 mg every 8 hours, fezolinetant rose by 40% and rose by 360%.1

  3. Report 3 · Study title

    Prescribing information: Veozah oral tablets, fezolinetant oral tablets

    When fezolinetant was given together with cimetidine (a weak ) 300 mg every 6 hours, fezolinetant rose by 30% and rose by 100%.1

Capmatinib and Fezolinetant: Common Questions

How serious is the Capmatinib and Fezolinetant interaction?

It is rated . These should generally not be used together.

How is the Capmatinib and Fezolinetant interaction managed?

The labeling for fezolinetant lists this combination as , meaning the two should not be used together. Here is what that usually looks like in practice: Your care team will typically choose a different approach for hot flashes so your cancer treatment with capmatinib can continue as planned. Do not stop or change either medicine on your own. Tell your pharmacist and prescribers abou… Management is individual — always follow your own care team's guidance.

Does taking Capmatinib and Fezolinetant at different times of day help?

No. Taking them at different times of day does not prevent this one. Capmatinib slows , an enzyme that breaks down fezolinetant, so fezolinetant can build up in the body. That change lasts while capmatinib is being taken and can continue for a while after the last dose.

Your pharmacist or prescriber can tell you how they will manage it.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Ask About the Capmatinib and Fezolinetant Interaction

Ask in your own words about taking Capmatinib and Fezolinetant together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: Veozah(TM) oral tablets, fezolinetant oral tablets. Astellas Pharma US, Inc, Northbrook, IL, 2023. DailyMed
Was this write-up helpful?

Other Serious Interactions of Capmatinib and Fezolinetant

Also serious with Capmatinib

Also serious with Fezolinetant

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Fezolinetant

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together. This interaction.
  • Major Potentially serious — often needs a change or close monitoring.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven. This interaction.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.